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SUMMARY
This study describes the epidemiology of community-acquired pneumonia (CAP) in elderly
Australians for the ﬁrst time. Using a case-cohort design, cases with CAP were in-patients aged
o65 years with ICD-10-AM codes J10-J18 admitted over 2 years to two tertiary hospitals. The
cohort sample was randomly selected from all hospital discharges, frequency-matched to cases by
month. Logistic regression was used to estimate risk ratios for factors predicting CAP or
associated mortality. A total of 4772 in-patients were studied. There were 1952 cases with CAP
that represented 4% of all elderly admissions : mean length of stay was 9.0 days and 30-day
mortality was 18%. Excluding chest radiograph, 520/1864 (28%) cases had no investigations
performed. The strongest predictors of CAP were previous pneumonia, history of other
respiratory disease, and aspiration. Intensive-care-unit admission, renal disease and increasing age
were the strongest predictors of mortality, while inﬂuenza vaccination conferred protection.
Hospitalization with CAP in the elderly is common, frequently fatal and a considerable burden
to the Australian community. Investigation is ad hoc and management empirical. Inﬂuenza
vaccination is associated with reduced mortality. Patient characteristics can predict risk of CAP
and subsequent mortality.
INTRODUCTION
Community-acquired pneumonia (CAP) is a leading
cause of morbidity and mortality in persons agedo65
years [1], with incidence and mortality rates increasing
with age [2]. An annual incidence of 10.4/1000 has
been reported from Spain for the elderly [3], while in
Finland, an annual incidence of 15/1000 in the 60–74
years age group has been reported, increasing to 34/
1000 for those agedo75 years [4]. Hospitalized cases
comprise the greatest burden from pneumonia in
terms of severity and health-care costs. This burden
is likely to increase in Australia as the population
ages.
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Periodic review of disease epidemiology can direct
management and preventive strategies. Data are cur-
rently lacking for many aspects of basic epidemiology
for CAP in elderly Australians given data availability
from only four small studies (<200 subjects) [5–8],
with none focusing on the elderly or examining risk
factors.
As part of a case-cohort study examining eﬀective-
ness of inﬂuenza vaccine and 23-valent pneumococcal
vaccine (23vPPV), we undertook a large study of CAP
in elderly Australians. This paper describe for elderly
in-patients : general epidemiology including season-
ality, burden of disease, mortality, risk factors for
CAP vs. non-CAP, and mortality for those with CAP.
Secondary outcomes include description of common
symptoms and signs associated with CAP, investi-
gation types performed and use of antimicrobial
agents.
METHODS
Study design
The case-cohort variant of the case-control design
includes a comparison group (the cohort) randomly
selected from the entire population from which cases
are drawn. Cohort selection is therefore represen-
tative of the source population, and independent of
case characteristics.Unlike a case-control study, where
controls are all unaﬀected persons, cases are also eli-
gible for inclusion in the cohort [9]. In addition, the
risk ratio is estimated directly from the ratio of inci-
dence proportions without requiring information
from every cohort member.
Study subjects
The study sampling frame included everybody aged
o65 years admitted to two large teaching hospitals
in Melbourne, Victoria from April 2000 to March
2002 inclusive, representing 11% of Victorian hospi-
talizations and 13% of pneumonia hospitalizations
for this age group [10]. Subjects with ICD-10-AM
codes J10-J18 (pneumonia including those due to in-
ﬂuenza) in any of the 14 diagnostic code positions
were considered to have pneumonia. Nosocomial
pneumonia was excluded (diagnosis >48 h after ad-
mission) [11].
Random oversampling of cohort subjects (1.2
times the number of cases per month) allowed for
exclusion of repeat admissions, and those also selected
as cases. For subjects with multiple admissions in
the same month, one episode was retained at ran-
dom. For month-to-month repeat admissions, the
ﬁrst selected admission was retained. Subjects were
excluded if non-Victorian residents, admitted for
short-stay procedures (e.g. dialysis, chemotherapy:
ICD-10-AM codes Z49.1, Z49.2 and Z51.1), trans-
ferred between hospitals with the same diagnosis,
or if hospital records were subsequently unavail-
able.
For seasonality, burden of disease and mortality,
ICD-10-coded pneumonia cases were compared with
ICD-10-coded non-pneumonia subjects. Where risk
factor analysis for CAP vs. non-CAP was conducted,
as per a case-cohort design, the entire cohort was the
comparison group. For secondary objectives, data
were available only for subjects with clinical notation
of pneumonia in hospital records. For inclusion in
these analyses, subjects were required to also have
ICD codes for pneumonia.
Data collection
Data on demographics, outcomes, comorbidities and
other potential predictors of CAP were obtained
by record review blinded to case status. Presence of
comorbidity was deﬁned as having at least one of :
excessive alcohol intake, current tobacco smoking,
history of pneumonia, aspiration, other respiratory
disease, diabetes, immunosuppression, ischaemic heart
disease, liver, renal, cerebrovascular or rheumato-
logical disease.
Radiology reports for chest radiographs (CXRs)
undertaken during routine management were re-
viewed by two research assistants. Pneumonia was
deﬁned as ‘ lobar ’ (opacity, lobar distribution only),
‘bronchopneumonia’ (opacity beyond one lobe plus
terms similar to/including ‘patchy’ and/or ‘air-
space’), ‘other ’ (opacity consistent with pneumonia
not previously classiﬁed) or ‘not pneumonia’. When
more than one CXR was performed during an ad-
mission, the ﬁrst abnormal report was reviewed
blinded to other reports. When reports could not be
conﬁdently interpreted, two of the investigators (S.S.
and D.C.) made the ﬁnal assessment after ﬁrst es-
tablishing high inter-operator agreement (kappa
>95%).
Additional data obtained from hospital and lab-
oratory records for secondary objectives included:
(1) investigations performed, (2) use of antimicrobial
agents, and (3) symptoms and signs usually associated
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with pneumonia [12, 13]. The latter included cough,
sputum, pleuritic chest pain, fever o37.5 xC, short-
ness of breath, crackles, and aspiration (present/
absent/not recorded).
The study was approved by the Human Re-
search Ethics Committee, Melbourne Health (ref.
2000.022).
Statistical methods
Logistic regression was used to estimate risk ratios for
factors predicting CAP or associated mortality. To
adjust for unequal probabilities of recruitment due to
multiple admissions, hospital of admission, and clus-
tering due to the monthly selection process, models
included month of discharge, hospital, and a weight
equal to the inverse of the total number of admissions
for each subject during the study period. Covariates
were ﬁrst assessed individually in logistic statements.
ThosewithP values<0.20were retained for backward
stepwise multivariate analysis with the exception of
variables with>15% missing data whose impact was
examined by addition only to the ﬁnal models.
Stepwise elimination of variables was determined by
removing the variable with the largest P value>0.05.
The ﬁnal model was determined when all remaining
variables had a P value<0.05. Stata version 9.1 was
used [14].
RESULTS
Study subjects
Of 4772 eligible study subjects, 1952 had ﬁrst pres-
entations with CAP and 2927 were ﬁrst- presentation
cohort subjects, including 107 also selected as cases
(Fig. 1).
Basic epidemiology and disease burden
In total, 1952 cases of CAP represented 4% (1952/
49 692) total admissions agedo65 years for the study
period in the two hospitals. A mean of 81 CAP ad-
missions occurred per month (median 81, range
50–125), peaking in winter (June–August 588/1952,
30%) and spring (September–November 490/1952,
25%) (Fig. 2).
Table 1 shows characteristics of in-patients with
CAP. Their mean/median age was 78 years. Males
comprised 58%. At least one comorbid condition
(mean 2.5, range 0–8) was present in 98% (1833/1870)
of cases.
The mean length of stay (LOS) for cases was 9 days
(median 6 days, range 0–100); signiﬁcantly longer
than for those without CAP (diﬀerence 3.8 days, 95%
CI 3.2–4.3). For those with CAP, older subjects aged
>79 years had a similar mean LOS to younger sub-
jects (65–79 years ; 9.0 vs. 8.9 days). Gender was not
signiﬁcantly associated with LOS, however, more
than two comorbid conditions was associated with
longer hospitalization (diﬀerence 1.1 days, 95% CI
0.2–2.1).
In-patients with CAP were admitted to intensive
care units (ICUs) more often than those with non-
CAP (278/1951, 14.2% vs. 291/2820, 10.3%; 95% CI
diﬀerence 2.0–8.6). Younger patients (65–79 years)
were much more likely to be admitted to an ICU than
patients aged o80 years (19.1%, 95% CI 16.7–21.4
vs. 8.0%, 95% CI 6.2–9.8; P<0.001). Neither gender
nor presence of more than two comorbidities were
associated with ICU admission.
Selected cases 2670
CAP cases 2244
(84%)
Eligible CAP cases
2186 (97%)
Excluded 2 duplicates
51 ineligible
Eligible first CAP
cases 1952 (89%)
5 lost records
Selected cohort 3204
Eligible first cohort
2927 (91%)
200 repeat admits 75 other
Fig. 1. Eligible ﬁrst presentation cases of community-
acquired pneumonia (CAP) and cohort subjects.
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Fig. 2. Seasonality of ﬁrst admissions with community-
acquired pneumonia (CAP), April 2000 to March 2002.
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Investigation
A CXR was performed for 1800/1861 (97%) subjects
with clinical notation and ICD codes for pneumonia.
Of these, 1736 (96%) had radiology reports available,
and 1731 (96%) had pneumonia type recorded:
bronchopneumonia for 617 (36%), lobar pneumonia
for 610 (35%), other pneumonia for seven (<1%)
and ‘not pneumonia’ for 497 (29%). Chest compu-
terized tomography was performed in 64/1863 (3%)
patients. The most common laboratory investigations
performed were on blood (including culture, poly-
merase chain reaction, immunoﬂuorescence: 1018/
1863, 55%), sputum (713/1864, 38%) and urine (in-
cluding urinary antigen: 310/1864, 17%). Less fre-
quent were nasopharyngeal aspirate (28/1864, 2%),
nose/throat swab (14/1864, 1%), and cerebrospinal
ﬂuid tap (8/1864,<1%). Excluding CXR, in-patients
with CAP had a mean of 1.2 investigation types
performed (range 0–6, median 1). Some had no
additional investigations (520/1864, 28%), o1 were
performed in 1344 (72%) ando2 in 641 (34%). The
most commonly identiﬁed pathogens were: inﬂuenza
A/B (41/1854 subjects, 2.2%), followed by Staphy-
lococcus aureus (17/1854, 0.9%) and S. pneumoniae
(11/1854, 0.6%).
Antimicrobial management
Of 1823/1854 (98%) subjects with data available
on antibiotic use, 1755 (96%) received antibiotics.
The most commonly prescribed were roxithromycin
(380, 21%), ceftriaxone (363, 20%), amoxycillin/
clavulanate (264, 14%), benzylpenicillin G (170, 9%),
erythromycin (114, 6%) and amoxycillin (70, 4%).
Clinical features
Clinical notation of pneumonia occurred for 1863/
1952 (95%) in-patients with CAP. These subjects had
Table 1. Characteristics of 1952* persons with ﬁrst admissions for
community-acquired pneumonia (CAP) and 2927 cohort subjects
Variable (%)#
CAP cases
(n=1952)
(95% CI)$
Cohort subjects
(n=2927)
(95% CI)
Mean age (years) 78.4 (78.0–78.7) 76.1 (75.8–76.4)
Male gender 57.7 (55.5–59.9) 50.9 (49.1–52.7)
Live in own home 19.5 (17.7–21.2) 12.5 (11.3–13.7)
First language English 70.4 (68.4–72.5) 73.1 (71.5–74.7)
Mean hospitalizations past year 1.2 (1.1–1.3) 1.4 (1.3–1.5)
Mean hospitalizations past 2–5 years 2.1 (2.0–2.3) 2.0 (1.8–2.1)
Diabetes 26.5 (22.6–26.4) 24.9 (23.3–26.4)
Ischaemic heart disease 46.6 (44.8–48.4) 53.0 (50.8–55.2)
Immunosuppression 27.0 (25.0–28.9) 23.9 (22.3–25.4)
Other respiratory disease 47.9 (45.7–50.1) 27.8 (26.2–29.4)
Renal disease 13.3 (11.8–14.8) 8.8 (7.7–9.8)
Rheumatological disease 15.7 (14.1–17.3) 17.0 (15.6–18.3)
Liver disease 2.6 (1.9–3.3) 2.0 (1.5–2.5)
Cerebrovascular disease 21.0 (18.4–21.3) 19.9 (19.1–22.7)
Aspiration 2.2 (1.6–2.9) 1.0 (0.6–1.3)
Previous pneumonia 22.2 (20.4–24.1) 11.4 (10.3–12.6)
Pneumonia past year 8.2 (7.0–9.5) 5.2 (4.4–6.0)
Pneumonia past 2–5 years 12.9 (11.4–14.4) 5.4 (4.6, 6.3)
Excessive alcohol intake* 20.1 (17.5–22.7) 14.0 (12.3–15.7)
Current smoker* 8.5 (7.0–9.9) 8.3 (7.1–9.4)
Current/Ex-smoker* 65.7 (63.2–68.2) 58.3 (56.3–60.4)
Death during hospitalization* 16.3 (14.7–18.0) 5.0 (4.2–5.8)
* Variables with missing data from medical record review (no. of subjects) : pre-
vious hospitalizations : 4 (0.2%), alcohol : 1027 (53%), smoking: 550 (28%),
deaths during hospitalization: 6 (0.3%); all other variables had no missing data.
# A detailed description of variables is available on request.
$ Percentage, unless labelled as a mean.
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a mean/median of 4/7 symptoms and signs of interest.
Three or fewer were present in 627/1863 (34%) sub-
jects and only four (0.2%) had all seven. Those most
frequently recorded and present were crackles, short-
ness of breath, cough, fever o37.5 xC and sputum
production (Table 2).
Risk factors for CAP
The ﬁnal multivariate model contained 14 indepen-
dent predictors of CAP (Table 3). Subjects with
pneumonia in the previous year, who spoke a ﬁrst
language other than English, or with a history of
rheumatological disease were under-represented in
the CAP group. Factors with no statistically signiﬁ-
cant association with CAP were vaccination status
with inﬂuenza vaccine or 23vPPV, marital status,
previous pneumonia (past year or 2–5 years), ischae-
mic heart disease, liver disease, cerebrovascular dis-
ease, prior hospitalizations (past year or 2–5 years),
comorbidity, years since receiving 23vPPV, smoking
habit or doctor visits (past 2–5 years).
Mortality and discharge location
Of 1946 in-patients with CAP and known discharge
location, discharge to one’s own home was most
common (65%) followed by other hospitals (9%),
nursing homes (5%) or hostel accommodation (2%).
Prior to admission, 81% of subjects with CAP lived
in their own home, 10% in nursing homes and 6% in
hostels. Subjects with CAP were more likely to be
discharged to a nursing home (diﬀerence 2.5%, 95%
CI 1.3–3.7) or the same hospital (diﬀerence 1.1%,
95% CI 0.4–1.7), but less likely to be discharged to
their own home (diﬀerencex16.8%, 95% CIx19.4
to x14.3) and more likely to die (diﬀerence 11.7%,
95% CI 10.0–13.6) compared to subjects without
CAP.
For the 1952 subjects admitted with CAP, 16.3%
died in hospital, 17.9% died within 30 days of ad-
mission, and 26.0% by the time of interview with next
of kin (Table 4). Subjects with CAP had a signiﬁcantly
higher in-hospital mortality rate (diﬀerence 11.7%,
95% CI 10.0–13.6) and if they did die in hospital,
a more rapid demise (diﬀerence x2.8 days, 95%
CI x5.5 to x0.1) compared with those with non-
CAP.
For those admitted to ICUs, mortality was signiﬁ-
cantly higher than the general hospital admission
mortality rate (104/566, 18.4% vs. 447/4749, 9.4%),
due to the higher mortality in those CAP in-patients
admitted to ICUs (Table 4).
Of note, 68/277 (24%) of those with CAP admitted
to ICUs were aged >79 years : 21 (31%) died in
hospital and 28 (41%) by the time of next-of-kin in-
terview. This was not signiﬁcantly higher than for
patients aged 65–79 years (diﬀerence x6.0%, CI
x18.4 to 6.4 and x12.1%, 95% CI x25.3 to 1.2
respectively). Older patients with CAP and >2 co-
morbid conditions were not signiﬁcantly more likely
to be admitted to an ICU than those with fewer
comorbid conditions (8.7% vs. 7.8%; diﬀerence
x0.9%, 95% CIx4.6 to 2.9).
Risk factors for in-hospital mortality associated
with CAP
The ﬁnal model contained nine independent pre-
dictors of mortality. Increased risk was associated
with ICU admission [risk ratio (RR) 2.68, 95% CI
1.90–3.76], renal disease (RR 1.78, 95% CI
Table 2. Frequency of symptoms and signs extracted from medical records
for 1863 subjects with clinical notation of pneumonia and ICD codes for
pneumonia
Symptom or sign
Present
n (%)
Absent
n (%)
Not recorded
n (%)
Crackles 1724 (92.5) 119 (6.4) 20 (1.1)
Shortness of breath 1447 (77.7) 346 (18.6) 70 (3.8)
Cough 1392 (74.7) 337 (18.1) 134 (7.2)
Fevero37.5 xC 1224 (65.7) 638 (33.8) 9 (0.5)
Sputum production 1038 (55.7) 614 (33.0) 211 (11.3)
Pleuritic chest pain 468 (25.1) 780 (41.9) 615 (33.0)
Evidence of aspiration 92 (4.9) 397 (21.3) 1374 (73.8)
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1.24–2.56), living in one’s own home (RR 1.68, 95%
CI 1.21–2.35), history of immunosuppression (RR
1.58, 95% CI 1.16–2.14), increasing age (P<0.001)
(RR 1.59 in the 75–59 years age group, increasing to
3.05 if o85 years), multi-lobe CXR opacity
(P<0.001; RR 3.0, 95% CI 2.1–4.3 vs. RR 1.4, 95%
CI 0.97–2.1) and smoking (P<0.001). Current
smokers were at greater risk than ex-smokers (RR 4.2,
Table 3. Predictors of community-acquired pneumonia for elderly in-patients, ﬁnal multivariate model
Variable Description Risk ratio (95% CI) P value
Increasing age group (yr) 65–69, 70–74, 75–79, 80–84,o85 — <0.001
Male gender Male vs. female 1.34 (1.18–1.53) <0.001
Living in own home Private residence vs.
group setting*
1.41 (1.17–1.70) <0.001
Diabetes Past history (yes/no) 1.22 (1.05–1.42) 0.01
Immunosuppression Yes/no# 1.35 (1.16–1.57) <0.001
Other respiratory disease Yes/no$ 2.41 (2.10–2.77) <0.001
Renal disease e.g. renal failure requiring
dialysis (yes/no)
1.57 (1.26–1.94) <0.001
Rheumatological disease Yes/no· 0.82 (0.69–0.98) 0.03
Aspiration History (yes/no) 2.19 (1.20–3.99) 0.01
First language English English vs other primary
language
0.80 (0.69–0.93) 0.003
Pneumonia ever Past history (yes/no) 2.30 (1.83–2.89) <0.001
Pneumonia past year Past history (yes/no) 0.66 (0.46–0.94) 0.02
Excess alcohol intakek History (yes/no) 1.34 (1.03–1.74) 0.03
Increasing doctor visits
past year"
0–4, 5–9, 10–14, 15–19,
o20 subject report
— <0.001
* For example, nursing home, retirement village, hostel, lodge, etc.
# AIDS, cancer (excluding basal cell carcinoma and squamous cell carcinoma), chronic steroid Rx, HIV infection before
development of AIDS, organ transplantation, dysgammaglobulinaemia, sickle cell disease, asplenia (functional or anatom-
ical), nephrotic syndrome.
$ Bronchitis, asthma, emphysema, other chronic obstructive airways disease (not pneumonia).
· Rheumatoid arthritis, osteoarthritis, systemic lupus erythematosus, multiple connective tissue disease.
k Medical record documentation including ‘alcoholism’, ‘alcohol abuse’, ‘EtOH abuse’ or alcohol consumption described
as in excess of 4 standard drinks/day for men and 2 standard drinks/day for women.
" ‘Excluded’ variable added only to ﬁnal model following backward stepwise process.
Table 4. Mortality for study subjects
All study
subjects (%) CAP only (%)
Non-CAP
only (%)
Diﬀerence (%)
(95% CI)
Mortality* 813/4772 507/1952 306/2820 15.1
(17.0) (26.0) (10.9) (12.9–17.4)
Mortality within 30 days
of admission*
507/4772
(10.6)
350/1952
(17.9)
157/2820
(5.6)
12.3
(10.4–14.3)
In-hospital mortality 447/4749 318/1946 129/2803 11.7
(9.4) (16.3) (4.6) (10.0–13.6)
In-hospital mortality within
30 days of admission
414/4772
(8.7)
299/1952
(15.3)
115/2820
(4.1)
11.2
(9.5–13.0)
Days until death (for deaths
in hospital)
10.6 (median 6)
range 0–100
9.8 (median 6)
range 0–100
12.6 (median 7)
range 0–99
x2.8
(x5.5–0.1)
ICU-related mortality#
(for deaths in hospital)
104/566 (18.4) 73/277 (26.3) 31/289 (10.7) 15.6 (9.3–21.9)
CAP, Community-acquired pneumonia ; ICU, intensive care unit.
* Includes deaths up until the time of interview with next of kin.
# Mortality in hospitalized subjects admitted to an ICU.
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95% CI 2.4–7.6 vs. RR 1.5, 95% CI 1.1–2.2). A re-
duction in risk of death was associated with inﬂuenza
vaccination in the year prior to admission (RR 0.55,
95% CI 0.40–0.76) and history of other respiratory
disease (RR 0.78, 95% CI 0.56–0.93).
DISCUSSION
Basic epidemiology
This study is the ﬁrst to speciﬁcally examine CAP in
elderly Australian in-patients and conﬁrms a con-
siderable disease burden, and seasonal pattern similar
to other countries [15]. Hospitalizations with CAP
represented 4% of all elderly admissions for the study
hospitals, consistent with the other Australian esti-
mate of 2% for all-aged adults [16].
In-patients with CAP had a mean LOS of 9 days,
consistent with previous studies (range 7–21 days)
[1, 17, 18]. This was on average 4 days longer than for
those admitted with non-CAP, contrasting with
Riquelme et al. who reported no diﬀerence [18]. Those
with >2 comorbidities were hospitalized on average
1 day longer, while gender and older age had no sig-
niﬁcant impact on LOS. Almost all those with CAP
had at least one comorbid condition; most frequently
non-pneumonia respiratory disease, ischaemic heart
disease, immunosuppression and diabetes; a pattern
consistent with previous small Australian studies of
all-age adults with CAP [5, 7] and a large American
cohort study [17].
The 14% ICU admission rate for CAP in-patients
was consistent with previous studies (range 2–22%)
[17, 19]. ICU admission occurred signiﬁcantly more
often than for non-CAP admissions (diﬀerence 4%).
Mean LOS for those with CAP admitted to ICUs was
15 days, similar to the United States (11 days) [17].
Younger elderly patients (<80 years) were much more
likely to be admitted to ICUs than older patients
(19% vs. 8%), consistent with Kaplan et al. (15% for
those<90 years vs. 27%) [17].
Risk factors for CAP
This study provides the ﬁrst Australian data on risk
factors for CAP in the elderly. Antecedent non-
pneumonia respiratory disease, pneumonia and as-
piration were most strongly predictive of CAP vs.
non-CAP, in addition to male gender, living in one’s
own home, history of diabetes, immunosuppression,
renal disease, excessive alcohol intake, increasing age
>75 years and numbers of doctor visits in the past
year. A large cohort study from Finland reported
similar ﬁndings for increasing age, immunosuppres-
sion, other lung disease and alcohol intake [20]. In-
patients experiencing pneumonia in the previous year
were under-represented in the CAP group, perhaps
due to increased contact with medical personnel or
awareness of early symptoms and signs of pneumonia
resulting in earlier intervention. The association be-
tween living in one’s own home and admission for
pneumonia may be related to isolation or fewer health
service prompts, although there are no data in the
scientiﬁc literature to support or refute this. It is un-
clear why having a ﬁrst language other than English
or a history of rheumatological disease might be
negatively correlated with CAP.
Mortality and discharge location
Although two thirds of those admitted with CAP re-
turned home (consistent with Conte et al. [19]) they
were less likely to do so than those admitted with non-
CAP, and more likely to be admitted to a nursing
home or die. Most deaths occurred within 30 days of
admission, as shown in North America [21]. Our 11%
30-day mortality rate is similar to previous small
Australian studies in non-Aboriginal populations
[6–8] and international studies [15, 19, 22].
Factors predictive of mortality in elderly persons
admitted with CAP in this study concur with earlier
studies, including history of renal disease [22], in-
creasing age [5, 8, 19, 21], multi-lobe involvement
on CXR [5, 18], admission to ICU [17] and immuno-
suppression [22]. This study also conﬁrms a con-
siderable risk reduction for mortality associated with
antecedent inﬂuenza vaccination [23] and increased
risk with current/previous smoking. The association
between inﬂuenza vaccination and mortality is dis-
cussed in greater detail elsewhere [24]. As for ad-
mission with CAP, it is unclear why living in one’s own
home was independently predictive of in-hospital
mortality.
Although those aged >80 years were less likely to
be admitted to ICUs, the mortality rate for those ad-
mitted was not signiﬁcantly higher than for younger
ICU patients with CAP. While suggesting aggressive
management in the very old is appropriate, these
ﬁndings are also consistent with a selection bias
favouring admission to ICUs for very old patients who
are less severely ill. While no signiﬁcant diﬀerences in
comorbidity were found for older patients admitted
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vs. not admitted to ICUs, we did not assess diﬀerences
in clinical severity. A future prospective study of
clinical features in these two groups could answer this
question.
Our data also indicate a risk reduction for death
associated with antecedent non-pneumonia respirat-
ory disease. Increased contact with respiratory spec-
ialists or greater awareness of clinical features of
pneumonia might result in seeking earlier care.
Similarly, health provider knowledge of the presence
of another respiratory condition might prompt earlier
intervention.
Clinical features
The most common clinical features noted for elderly
persons admitted with CAP were similar to those
described in previous studies [12, 13]. Of note, two
thirds of subjects had three or fewer features present,
consistent with the less distinct clinical presentation
described for older patients [25].
Investigations and antimicrobial management
Almost all patients with clinical notation and ICD
codes for pneumonia had a CXR performed. About
30% had reports inconsistent with pneumonia,
suggesting this remains an imperfect approach for
retrospectively identifying elderly in-patients with
pneumonia.
Although not designed to examine investigations,
causative organisms or antimicrobial agent use in any
detail, some general observations can be made from
this study. Over one quarter of elderly persons ad-
mitted with CAP had no laboratory investigations
performed, and of those who did, most had only one
type (e.g. a blood test), indicating that an empirical
approach to management is frequently used and
many will not have a causative organism identiﬁed.
However, as noted above, survival rates appear simi-
lar to those in countries such as the United States
where investigation to determine a causative organism
is more usual. Almost all patients with CAP received
antibiotics during admission and these were consist-
ent with current guidelines [26]. There were too few
investigations identifying a causative organism to
make any meaningful interpretation of those found.
Study limitations
Retrospective hospital record review meant that
while some variables were well documented, others
captured non-uniform practices of staﬀ. While it is
possible that some subjects did not have pneumonia,
we have previously shown that ICD-10 codes are a
valid tool for retrospective identiﬁcation of hospital-
ized cases [27]. This study was conducted in hospital-
ized elderly persons and may not be generalizable to
the wider elderly population, although estimates for
vaccination coverage were similar to the general eld-
erly Victorian community [28].
Conclusions
This study of CAP provides the most comprehensive
epidemiological dataset for elderly Australians to
date, including the ﬁrst on risk factors and associated
mortality. It conﬁrms that hospitalization with
CAP in the elderly is common, frequently fatal and a
considerable burden to the community. Investigation
remains ad hoc and the approach to management
empirical. A prospective study of pneumonia in-
corporating a systematic approach to investigation in
Australia could make a valuable contribution to
understanding causative organisms and better direct
treatment options. The disparity in ICU admission
rates between older and younger elderly patients
raises the question of whether their similar ICU
survival rates reﬂect preferential admission of older
patients likely to have a good prognosis. Inﬂuenza
vaccination should continue to be promoted in this
population as it is associated with reduced mortality
for those hospitalized with CAP. Further evidence is
produced to advocate smoking cessation. For health
practitioners, characteristics present at admission
predict likelihood of CAP and risk of mortality.
Greater awareness of risk factors such as aspiration
and alcoholism could potentially lead to implemen-
tation of preventive strategies and improved out-
comes.
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